IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CAMERA, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.673
AS - Asia 11.983
NA - Nord America 11.742
SA - Sud America 1.131
AF - Africa 224
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 40
Totale 39.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.409
GB - Regno Unito 4.832
CN - Cina 3.852
SG - Singapore 3.399
IT - Italia 2.601
DE - Germania 1.815
SE - Svezia 1.262
RU - Federazione Russa 1.260
HK - Hong Kong 1.025
BR - Brasile 813
VN - Vietnam 764
FR - Francia 635
TR - Turchia 634
IN - India 614
KR - Corea 515
IE - Irlanda 467
NL - Olanda 428
BD - Bangladesh 399
FI - Finlandia 376
UA - Ucraina 360
EU - Europa 284
CA - Canada 235
PL - Polonia 206
ID - Indonesia 174
JP - Giappone 152
CO - Colombia 108
PH - Filippine 94
AR - Argentina 76
DK - Danimarca 68
GR - Grecia 59
AU - Australia 49
MX - Messico 49
AT - Austria 48
CI - Costa d'Avorio 48
BE - Belgio 43
IQ - Iraq 42
ES - Italia 41
CL - Cile 40
PK - Pakistan 39
ZA - Sudafrica 38
EC - Ecuador 35
EG - Egitto 35
SA - Arabia Saudita 27
CH - Svizzera 26
RO - Romania 26
UZ - Uzbekistan 26
NO - Norvegia 25
VE - Venezuela 23
MY - Malesia 22
MA - Marocco 20
IL - Israele 18
AZ - Azerbaigian 17
TW - Taiwan 17
NP - Nepal 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
JO - Giordania 15
KZ - Kazakistan 15
CZ - Repubblica Ceca 14
PE - Perù 14
DZ - Algeria 13
TH - Thailandia 13
TN - Tunisia 13
LB - Libano 12
KE - Kenya 11
NZ - Nuova Zelanda 11
TT - Trinidad e Tobago 11
AL - Albania 10
LU - Lussemburgo 10
PT - Portogallo 10
UY - Uruguay 10
HN - Honduras 9
OM - Oman 9
SI - Slovenia 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
RS - Serbia 7
BO - Bolivia 6
ET - Etiopia 6
LK - Sri Lanka 6
LT - Lituania 6
SC - Seychelles 6
AM - Armenia 5
BG - Bulgaria 5
LV - Lettonia 5
NG - Nigeria 5
PY - Paraguay 5
BH - Bahrain 4
CG - Congo 4
JM - Giamaica 4
SN - Senegal 4
BN - Brunei Darussalam 3
CR - Costa Rica 3
CY - Cipro 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
MN - Mongolia 3
MU - Mauritius 3
NI - Nicaragua 3
Totale 40.043
Salva come PNG Salva come JPEG
Città #
Southend 4.513
Singapore 1.891
Ashburn 1.068
Hong Kong 946
Milan 863
Chandler 847
San Jose 815
Beijing 720
Dallas 659
Seattle 656
Princeton 534
Wilmington 495
Frankfurt am Main 486
Dublin 456
Council Bluffs 429
Hanover 365
Fairfield 324
Santa Clara 321
Mountain View 309
Los Angeles 293
Redmond 287
Nanjing 251
Ho Chi Minh City 238
Lauterbourg 226
Bengaluru 224
Dearborn 210
Sakarya 197
Woodbridge 175
Moscow 173
Des Moines 172
Guangzhou 171
Ann Arbor 167
Buffalo 165
Hanoi 163
Jacksonville 161
New York 161
Boardman 157
Hefei 151
Seoul 131
Helsinki 130
Warsaw 130
Shanghai 122
Jinan 119
Cambridge 118
Centro 112
Houston 106
Shenyang 105
Somerville 104
Jakarta 102
Munich 97
Rome 95
Hangzhou 94
Tianjin 92
Andover 91
Tokyo 88
Serra 86
The Dalles 85
Bogotá 84
Berlin 82
Changsha 79
Columbus 77
Cangzhou 71
Nanchang 69
Phoenix 69
Toronto 67
Ottawa 65
São Paulo 65
Shenzhen 63
Zhengzhou 63
Bitonto 62
Hebei 56
Eitensheim 54
Grafing 54
Redwood City 53
Athens 50
Jiaxing 50
Chicago 49
Abidjan 48
Medford 48
Da Nang 41
Bühl 40
London 40
Istanbul 39
Taizhou 37
Ningbo 36
Turin 36
Fuzhou 35
Brussels 34
Pisa 34
San Diego 34
Wuhan 32
Haiphong 31
Hamburg 29
Nuremberg 29
Bologna 27
Kunming 27
Padova 27
Atlanta 26
Rio de Janeiro 25
Roxbury 25
Totale 24.508
Salva come PNG Salva come JPEG
Nome #
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 670
The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease : Insights into Platelet Tissue Factor 534
PCSK9 induces a pro-inflammatory response in macrophages 391
Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats 382
PCSK9 as a Positive Modulator of Platelet Activation 353
MicroRNA-222 Regulates Melanoma Plasticity 341
Repurposing of drugs approved for cardiovascular diseases : Opportunity or mirage? 307
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics : Effects of Improved Dosing Regimens 306
Drug repurposing in cardiovascular diseases : Opportunity or hopeless dream? 306
D-dimer is associated with arterial and venous coronary artery bypass graft occlusion 305
Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients 298
Tissue factor gene promoter haplotype associates with carotid intima-media thickness in subjects in cardiovascular risk prevention 294
Nuove acquisizioni sull'aterosclerosi: placca vulnerabile : relazione su invito 276
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction) : results of a prospective, multicenter study 275
Do methodological differences account for the current controversy on tissue factor expression in platelets? 266
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients : the baseline findings of the MIAMI study 264
Migraine in Patients Undergoing PFO Closure: Characterization of a Platelet-Associated Pathophysiological Mechanism: The LEARNER Study 261
Endothelial Dysfunction in Patients with Severe Mitral Regurgitation 259
Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery 255
Biological profile of monocyte-derived macrophages in coronary heart disease patients : implications for plaque morphology 252
Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients 249
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections 248
An Intense and Short-Lasting Burst of Neutrophil Activation Differentiates Early Acute Myocardial Infarction from Systemic Inflammatory Syndromes 245
The MIAMI study (Markers of Inflammation and Atorvastatin effect in previous Myocardial Infarction): results of a prospective, open-label, multicenter study 241
Oxidized LDL-dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy 241
Vitamin d plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes : a prospective study 239
Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis 238
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL 235
Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain 235
The MIAMI Study (Markers of inflammation and Atorvastatin effect in previous myocardial infarction): Results of a prospective, open-label, multicenter Study. 234
Platelet behaviour in patients with drug-eluting stents after thienopyridine treatment discontinuation 233
PCSK9 promotes arterial medial calcification 233
Fibrillar collagen inhibits cholesterol biosynthesis in human aortic smooth muscle cells 232
Inflammatory Markers and Carotid Intima Media Thickness (C-IMT) in Stable IHD Patients 229
Antithrombotic and anti-inflammatory properties of rosuvastatin in cultured human endothelial cells 226
Biochemical and mechanical properties of intraluminal thrombus from human abdominal aortic aneurysm 221
Comparative transcript profiling of human platelets from patients with stable angina and acute coronary syndromes 221
Lipoproteine aterogene e sintesi di PAI-1 da parte di cellule endoteliali 220
Synthesis of long-chain polyunsaturated fatty acids is inhibited in vivo in hypercholesterolemic rabbits and in vitro by oxysterols 219
A standardized stimulus augment CRP similarly in patients with a history of stable or unstable 218
PCSK9 Involvement in Aortic Valve Calcification 217
Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study 216
Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up 214
Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits 213
The ATROCAP Study: atorvastatin and the thrombogenicity of carotid atherosclerotic plaque 212
Nonrheumatic calcific aortic stenosis : an overview from basic science to pharmacological prevention 211
Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis 210
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment 209
Tissue factor in patients with acute coronary syndromes : expression in platelets, leukocytes, and platelet-leukocyte aggregates 207
Effetti di Atorvastatina su markers solubili aterosclerosi carotidea : Risultati dello Studio MIAMI 206
Diversity and similarity in signaling events leading to rapid COX-2 synthesis by PMA and TNFin human endothelial cells 205
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery 205
Proteome of platelets in patients with coronary artery disease 203
Lipoproteine aterogene e trombosi: aspetti cellulari 203
Vitamin D and cardiovascular disease: Current evidence and future perspectives 202
ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism 201
Platelet activation in patients undergoing carotid artery stenting procedure 199
Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity 198
Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice 196
Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document 196
E-Selettina e l’inibitore del fattore tissutale (TFPI) correlano con l’inspessimento medio-intimale carotideo (C-IMT) in pazienti con malattia ischemica coronarica in fase di stabilità clinica: risultati basali dello Studio MIAMI 195
Vascular thrombogenicity induced by progressive LDL oxidation : protection by antioxidants 195
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL 192
Multidetector computed tomography (mdct): able to define the plaque composition as assessed by histology? 189
Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells 188
Expression of alternatively spliced tissue factor in human endothelial cells : induction by inflammatory stimuli and modulation by heparins 187
Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome 186
Human megakaryocytes confer tissue factor to a subset of shed platelets to stimulate thrombin generation 185
Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention 183
Oxidized phospholipids inhibit cyclooxygenase-2 in human macrophages via nuclear factor-kappaB/IkappaB- and ERK2-dependent mechanisms 183
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process 182
HuR RNA-binding protein in acute coronary syndrome : stabilization of platelet TF and COX-1 MRNAs 181
Platelet behaviour after thienopyridine treatment discontinuation in patients with DES 179
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting 178
E-selectin and TFPI are associated with carotid intima-media thickness in stable coronary patients : the baseline findings of the MIAMI Study 177
Soluble E-Selectin and tissue factor pathway inhibitor, but not C-reactive protein, correlate with carotid intima-media thickness (C-IMT) in stable coronary patients: the baseline data of the MIAMI Study 177
Atherosclerotic plaque as a therapeutic target. The ATROCAP Study (Atorvastatin and Thrombogenicity of Carotid Atherosclerotic Plaque). 177
Plasminogen activator inhibitor type-1 mRNA expression is increased by triglyceride rich lipoproteins in human hepatoma cells 175
Triglycerides and the fibrinolytic system 175
Triglycerides and the fibrinolytic system 174
Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery 173
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation 172
Chemotactic effect of prorenin on human aortic smooth muscle cells : a novel function of the (pro)renin receptor 172
Titolare di un progetto di Ricerca finanziato dalla Fondazione Italo Monzino dal titolo "Nuovi meccanismi patogenetici delle sindromi coronariche acute: Identificazione dei meccanismi molecolari coinvolti nelle alterazioni del trascrittoma piastrinico osservate nella malattia coronarica 171
Eicosanoids and Their Drugs in Cardiovascular Diseases : Focus on Atherosclerosis and Stroke 170
Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon 170
Patho- physiological role of BDNF in fibrin clotting 170
Platelet transcriptome profiling in stable angina and non-st elevation acute coronary syndrome 169
PLATELET PROTHROMBOTIC AND TRANSCRIPTOMIC PROFILE IN CAD PATIENTS WITH TYPE-2 DIABETES MELLITUS 168
Platelet activation in patients undergoing carotid artery stenting procedure 166
Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice : a clue to the disputed activity of statins on HDL 166
Human carotid plaque composition: Correlation between histology and Multidetector computed tomography (MDCT) 164
Montelukast inhibits platelet activation induced by plasma from COVID-19 patients 164
Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study 163
Lack of transcriptional effects on apoA-I by Rosuvastatin in a transgenic mouse model 163
Distinct roles for PAR-1 and PAR-2 mediated vasomotor modulation in human arterial and venous conduits used in coronary artery bypass surgery 162
V Congresso monotematico della SIF. Aterotrombosi: dalla ricerca di base alla clinica. Milano, 3-4 Novembre 2011. Organizzazione e segreteria scientifica. 162
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS 162
α-melanocyte stimulating hormone inhibits fetal vascular smooth muscle cell phenotypic switching 162
Platelet transcriptome profiling in stable angina and non-ST elevation acute coronary syndrome 161
Totale 22.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021916 0 0 0 0 0 0 0 0 0 0 739 177
2021/20223.061 239 118 139 127 243 289 253 205 277 281 373 517
2022/20233.539 551 308 266 397 374 690 106 198 350 52 158 89
2023/20242.290 83 164 140 226 491 164 82 101 65 128 321 325
2024/20255.683 225 540 152 505 525 233 238 599 329 492 521 1.324
2025/202611.373 1.047 715 1.408 872 992 835 1.563 654 1.367 853 1.067 0
Totale 41.934